Adis Journals
Browse

Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels

Download (63.48 kB)
media
posted on 2020-07-24, 10:22 authored by Masaomi Takizawa, Dirk Cerneus, Ingrid Michon, Sanne Rijnders, John Meijer, Akiyoshi Someya, Yuichiro Sato
<p>The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).<br></p> <p>© The authors, CC-BY-NC 2020.</p>

History

Related Materials

  1. 1.
    URL - References https://link.springer.com/article/10.1007/s12325-020-01451-6
  2. 2.
    DOI - Is supplement to Investigation of Safety and Tolerability of ASP3652 Based on Clinical Studies of Cerebrospinal Fluid Transfer After Multiple Doses and Exposure After Single Doses at High Dose Levels

Usage metrics

    Advances in Therapy

    Categories

    Keywords

    AnandamideCerebrospinal fluidEndocannabinoidFatty acid amide hydrolaseHealthy subjectsPharmacodynamicsPharmacokinetics

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC